The Valley Desk

NCT05883748 · Interventional trial

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Overall registry status Enrolling by invitation

Phase 2 · Phase 3

Conditions Erythropoietic Protoporphyria

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov